This was a persistent plea to open a vista of New Happenings at the website of Sudha Foundation, an organization designed to reach out the millions of people needing to be steered through the maze of medical care.
Cancer is a disease that begins as a renegade human cell over which the body has lost control. In order for the body and its organs to function properly, cell growth needs to be strictly regulated. Cancer cells, however, continue to divide and multiply at their own speed, forming abnormal lumps, or tumors. An estimated 6.7 million people currently die from cancer every year.Not all cancers are natural-born killers.Some tumors are referred to as benign because they don't spread elsewhere in the body
More than 19.5 million cancer deaths were recorded in the United States from 1980 to 2014. When digging deeper, the Institute for Health Metrics and Evaluation at the University of Washington found that cancer deaths were “clustered,” with many U.S. counties above the national average. Of note, there were statistically significant increases in cancer mortality between 1980 and 2014 in 160 counties, with the highest rates of increase observed in Kentucky and scattered across regions of the South.
The National Cancer Institute (NCI) today launched a new drug formulary (the “NCI Formulary”) that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials. The NCI Formulary could ultimately translate into speeding the availability of more-effective treatment options to patients with cancer. The NCI Formulary is a public-private partnership between NCI, part of the National Institutes of Health, and pharmaceutical and biotechnology companies.